Cresco Labs Inc. (CSE:CL)

Market Cap	581.61M
Revenue (ttm)	923.81M
Net Income (ttm)	-62.30M
Shares Out	356.82M
EPS (ttm)	-0.18
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,524
Average Volume	214,342
Open	1.600
Previous Close	1.630
Day's Range	1.570 - 1.610
52-Week Range	0.610 - 2.220
Beta	1.97
RSI	45.86
Earnings Date	Nov 5, 2025

About Cresco Labs

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 2,900
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: CL

Financial Performance

In 2024, Cresco Labs's revenue was $715.76 million, a decrease of -5.33% compared to the previous year's $756.06 million. Losses were -$74.44 million, -57.59% less than in 2023.

Financial numbers in USD